Onconic Therapeutics Statistics

Total Valuation

KOSDAQ:476060 has a market cap or net worth of KRW 262.41 billion. The enterprise value is 218.19 billion.

Market Cap	262.41B
Enterprise Value	218.19B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:476060 has 11.00 million shares outstanding.

Current Share Class	11.00M
Shares Outstanding	11.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.62%
Owned by Institutions (%)	13.54%
Float	5.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.57
PB Ratio	4.50
P/TBV Ratio	4.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-69.01
EV / Sales	9.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-47.88

Financial Position

The company has a current ratio of 13.16, with a Debt / Equity ratio of 0.00.

Current Ratio	13.16
Quick Ratio	12.79
Debt / Equity	0.00
Debt / EBITDA	1.02
Debt / FCF	-0.06
Interest Coverage	-1.11

Financial Efficiency

Return on equity (ROE) is -12.05% and return on invested capital (ROIC) is -0.45%.

Return on Equity (ROE)	-12.05%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-0.45%
Return on Capital Employed (ROCE)	-0.33%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.98B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22,745.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	41.28
Average Volume (20 Days)	314,111

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:476060 had revenue of KRW 22.69 billion and -3.16 billion in losses. Loss per share was -291.84.

Revenue	22.69B
Gross Profit	22.68B
Operating Income	-192.43M
Pretax Income	-5.14B
Net Income	-3.16B
EBITDA	258.38M
EBIT	-192.43M
Loss Per Share	-291.84

Full Income Statement

Balance Sheet

The company has 44.48 billion in cash and 263.70 million in debt, giving a net cash position of 44.22 billion or 4,018.86 per share.

Cash & Cash Equivalents	44.48B
Total Debt	263.70M
Net Cash	44.22B
Net Cash Per Share	4,018.86
Equity (Book Value)	58.37B
Book Value Per Share	5,363.96
Working Capital	49.82B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.43 billion and capital expenditures -129.28 million, giving a free cash flow of -4.56 billion.

Operating Cash Flow	-4.43B
Capital Expenditures	-129.28M
Free Cash Flow	-4.56B
FCF Per Share	-414.22

Full Cash Flow Statement

Margins

Gross margin is 99.98%, with operating and profit margins of -0.85% and -13.93%.

Gross Margin	99.98%
Operating Margin	-0.85%
Pretax Margin	-22.66%
Profit Margin	-13.93%
EBITDA Margin	1.14%
EBIT Margin	-0.85%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:476060 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.20%
FCF Yield	-1.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:476060 has an Altman Z-Score of 26.38.

Altman Z-Score	26.38
Piotroski F-Score	n/a